carbon C 14 fluzoparib
Term · Oncology and biomedicine · MLC-T-ONC-012273
An orally bioavailable radioconjugate composed of fluzoparib, an orally bioavailable inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2, radiolabeled with the radioisotope carbon C 14, with potential use for evaluating the pharmacokinetic profile of fluzoparib. Upon administration of carbon C 14 fluzoparib, fluzoparib targets, binds to and inhibits PARP, which results in the inhibition of tumor cell proliferation and survival. Labeling of fluzoparib with the radioactive tracer carbon C 14 allows for the evaluation of fluzoparib's pharmacokinetic profile, including its absorption, distribution, metabolism and excretion (ADME).
| Identifier | MLC-T-ONC-012273 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 14C-fluzoparib; [14C]-fluzoparib |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012273",
"term": "carbon C 14 fluzoparib",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable radioconjugate composed of fluzoparib, an orally bioavailable inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2, radiolabeled with the radioisotope carbon C 14, with potential use for evaluating the pharmacokinetic profile of fluzoparib. Upon administration of carbon C 14 fluzoparib, fluzoparib targets, binds to and inhibits PARP, which results in the inhibition of tumor cell proliferation and survival. Labeling of fluzoparib with the radioactive tracer carbon C 14 allows for the evaluation of fluzoparib's pharmacokinetic profile, including its absorption, distribution, metabolism and excretion (ADME).",
"synonyms": [
"14C-fluzoparib",
"[14C]-fluzoparib"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carbon-c-14-fluzoparib/"
}
Record 4,177 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.